Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data
This narrative review describes and appraises some relatively new studies investigating the efficacy and safety profile of soluble guanylate cyclase stimulator riociguat in patients suffering from pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It has...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Столичная издательская компания
2020-05-01
|
| Serija: | Рациональная фармакотерапия в кардиологии |
| Teme: | |
| Online dostop: | https://www.rpcardio.online/jour/article/view/2180 |
| Oznake: |
Brez oznak, prvi označite!
|